ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag survey neuroscience immunology developmental biology

Cancer cell
Interrogating the Complexities of the Tumor Microenvironment
Alison Halliday, PhD, Technology Networks | May 19, 2023 | 5 min read
Gaining a better understanding of the dynamic and reciprocal interactions between cancer cells and the tumor microenvironment is essential for improving patient diagnosis and treatment.
Life Sciences Salary Survey 2011
Jef Akst and Edyta Zielinska | Dec 1, 2011 | 10+ min read
US salaries are starting to recover after last year’s survey recorded the first-ever drop.
How Much Do You Make?
The Scientist | May 16, 2012 | 1 min read
Fill out our annual Salary Survey to help us calculate the most current salary data for life scientists.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Howard Hughes Medical Institute Enriches Undergrad Science Studies
Linda Marsa | Jan 6, 1991 | 5 min read
This year, five graduating seniors from Atlanta's Morehouse College, one of the top historically black institutions in the United States, plan on attending graduate school in science. "That's up from zero last year, so this represents a giant step forward," says J.K. Haynes, chairman of the biology department at Morehouse. "If one college can place five minority students in graduate science programs every year, that's making a major contribution. And we see this trend continuing." Haynes belie
Roll-Your-Own Microarrays
Jim Kling | Jan 6, 2002 | 3 min read
CDNA microarrays hold great promise for characterizing disease and performing genetic studies, but they're not exactly an out-of-the-box technology just yet. Often the scientists must prepare their own chips. Yet, this process is limited by the amount of space on the array itself—forcing researchers to make choices about which genes to include in their sample. Clinical microarray applications are further limited by the availability of sufficient cell numbers for testing purposes. Illumina
From Scholars to Scientists
The Scientist Staff | Nov 21, 2004 | 6 min read
is assembled one of the most prestigious biomedical communities in the world.
New Approaches to Discovery Push Research at Big Biotech
James Kling | May 24, 1998 | 6 min read
The biotechnology industry is among the biggest employers of life science professionals, with 140,000 employees generating $17.4 billion of revenue in 1997, according to an industry report by Ernst & Young LLP of Palo Alto, Calif. Since the birth of biotechnology in the 1970s, many of the seminal companies--such as Biogen and Genentech-- have matured into profitable or near- profitable companies. As these companies arose, venture capitalists fell in love with start-up biotechs in the 1980s
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,

Run a Search

ADVERTISEMENT